Rami Katkhuda
Stock Analyst at LifeSci Capital
(4.86)
# 374
Out of 5,004 analysts
339
Total ratings
51.1%
Success rate
27.9%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Rami Katkhuda
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABSI Absci | Reiterated: Buy | $16 | $9.74 | +64.27% | 2 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Reiterated: Buy | $8 | $2.65 | +201.89% | 44 | Sep 22, 2026 | |
| MAZE Maze Therapeutics | Reiterated: Buy | $57 | $26.05 | +118.81% | 8 | Sep 22, 2026 | |
| VERA Vera Therapeutics | Reiterated: Buy | $90 | $32.54 | +176.58% | 40 | Sep 15, 2026 | |
| IRON Disc Medicine | Reiterated: Buy | $100 | $65.24 | +53.28% | 41 | Sep 10, 2026 | |
| JBIO Jade Biosciences | Reiterated: Buy | $42 | $14.42 | +191.26% | 6 | Sep 3, 2026 | |
| AMLX Amylyx Pharmaceuticals | Reiterated: Buy | $44 | $29.49 | +49.20% | 17 | Aug 22, 2026 | |
| YARW Yarrow Bioscience | Reiterated: Buy | $56 | $25.54 | +119.26% | 24 | Aug 13, 2026 | |
| ELOX Eloxx Pharmaceuticals | Reiterated: Buy | $40 | $15.03 | +166.13% | 2 | Aug 12, 2026 | |
| MLYS Mineralys Therapeutics | Reiterated: Buy | $54 | $25.86 | +108.82% | 25 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $170 | $116.57 | +45.84% | 4 | Aug 11, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $33 | $12.04 | +174.09% | 42 | Aug 10, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $35 | $20.47 | +70.98% | 48 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $125 | $88.55 | +41.16% | 24 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 | $3.37 | +315.43% | 12 | Mar 31, 2026 |
Absci
Sep 24, 2026
Reiterated: Buy
Price Target: $16
Current: $9.74
Upside: +64.27%
Eledon Pharmaceuticals
Sep 22, 2026
Reiterated: Buy
Price Target: $8
Current: $2.65
Upside: +201.89%
Maze Therapeutics
Sep 22, 2026
Reiterated: Buy
Price Target: $57
Current: $26.05
Upside: +118.81%
Vera Therapeutics
Sep 15, 2026
Reiterated: Buy
Price Target: $90
Current: $32.54
Upside: +176.58%
Disc Medicine
Sep 10, 2026
Reiterated: Buy
Price Target: $100
Current: $65.24
Upside: +53.28%
Jade Biosciences
Sep 3, 2026
Reiterated: Buy
Price Target: $42
Current: $14.42
Upside: +191.26%
Amylyx Pharmaceuticals
Aug 22, 2026
Reiterated: Buy
Price Target: $44
Current: $29.49
Upside: +49.20%
Yarrow Bioscience
Aug 13, 2026
Reiterated: Buy
Price Target: $56
Current: $25.54
Upside: +119.26%
Eloxx Pharmaceuticals
Aug 12, 2026
Reiterated: Buy
Price Target: $40
Current: $15.03
Upside: +166.13%
Mineralys Therapeutics
Aug 12, 2026
Reiterated: Buy
Price Target: $54
Current: $25.86
Upside: +108.82%
Aug 11, 2026
Reiterated: Buy
Price Target: $170
Current: $116.57
Upside: +45.84%
Aug 10, 2026
Reiterated: Buy
Price Target: $33
Current: $12.04
Upside: +174.09%
Aug 6, 2026
Reiterated: Buy
Price Target: $35
Current: $20.47
Upside: +70.98%
Aug 4, 2026
Reiterated: Buy
Price Target: $125
Current: $88.55
Upside: +41.16%
Mar 31, 2026
Reiterated: Buy
Price Target: $14
Current: $3.37
Upside: +315.43%